The tissues were obtained after decapitation of the animals. Briefly, the tissues was 154 excised, weighed, washed in ice-cold buffer and minced. The minced tissue was rinsed with 155 cold isolation buffer to remove blood and homogenized in a glass Potter-Elvehjem 156 homogenizer with a motor-driven Teflon pestle on ice. The isolation buffer consisted of 120 157 mM KCl, 2 mM K 2 CO 3 , 10 mM HEPES and 1 mM EDTA; pH of 7.2 was adjusted with 158
KOH. 159
Experimental groups. 160
The mice were randomly assigned into four groups: untreated controls (6 animals), 161 melatonin group (6 animals), LPS group (6 animals) and LPS + melatonin group (6 animals). were carried out at 22 ± 0.5°C using a Specol 11 spectrophotometer (Carl Zeiss Jena, 224
Germany) in duplicate. 225
Statistical analysis. 226
Results are expressed as mean ± S.E.M. All variables were tested for a normal 227 distribution using the Kolmogorov-Smirnov and Lilliefors tests (p>0.05) and the homogeneity 228 of variance was checked by using Levene's test. The significance of differences in the level of 229 lipid peroxidation, amino acid carbonyl derivatives and antioxidant enzyme activities between 230 the control and test groups were examined using one-way analysis of variance (ANOVA). We 231 used Bonferonni's post-hoc test. Differences were considered significant at p<0.05. In 232 addition, the associations between data of all individuals were evaluated using Pearson's 233 correlation analysis. All statistical calculations were performed using data from each 234 individual with STATISTICA 8.0 software (StatSoft Inc., Poland). 235 236 237 Results
238
LPS administration was associated with the free radical oxidation of lipids. As the 239 process occurs in several stages, we decided to assess the degree of change at the beginning 240 and the end of the lipoperoxidation process (LPO). Diene conjugation is considered to be a 241 D r a f t primary product following the formation of diene conjugates and ketodienes (Fig. 1) . 242
Consequently, we estimated the initial substrate accumulation in this stage of free radical 243 oxidation in different tissues. After LPS treatment, the concentration of conjugated dienes was 244 significantly higher in the liver (F=11.34, p=0.000), muscle (F=4.22, p=0.001) and kidney 245 (F=14.12, p=0.000) compared to those observed in control mice. Melatonin statistically 246 decreased the concentration of conjugated dienes in all tissues compared to the LPS-treated 247 mice. 248
The MDA concentration, as an end product of the terminal stages of free radical 249 oxidation of lipids, and an oxidative stress marker, namely TBARS, may be used to estimate 250 the level of oxidative stress; this was the next step in our investigation (Fig. 2) . The MDA 251 value changed significantly in all analyzed tissues. In the liver (F=10.94, p=0.000), muscle 252 (F=4.64, p=0.002) and kidney (F=3.64, p=0.001), the intensity of the lipid peroxidation 253 process was significantly higher after LPS administration compared to the control group. We 254 found a statistically significant decrease in MDA in those tissues after melatonin treatment in 255 LPS-treated mice. 256 ROS are implicated as important pathologic agents in many disorders. In the present 257 study, we determined the level of OMP (Table 1) ; OMP-AD and KD derivatives were higher 258 in the liver (F=18.78, p=0.000 for AD and F=22.23, p=0.000 for KD respectively), muscle 259 (F=13.25, p=0.000 for AD) and kidney (F=19.03, p=0.000 for KD) following LPS treatment. 260
Our results show a consistent trend toward an increase in the concentration of OMP such as 261 AD and KD in all investigated tissues in the LPS-treated group. In muscle tissue, we observed 262 an increased OMP KD concentration after melatonin administration in LPS-treated mice. 263
Otherwise, melatonin either decreased OMP levels (AD in the liver, KD in the kidney) or 264 levels did not change. 265
Our results show that the TAC level (Fig. 3) was statistically lower after LPS treatment 266 in the liver (F=10.34, p=0.000), muscle (F=10.17, p=0.000) and kidney (F=13.45, p=0.000) 267 compared to the control. In liver tissue, melatonin treatment increased the TAC level 268 compared to the control group. Melatonin administration to LPS-treated mice either restored 269 or even increased the TAC concentration in all investigated tissues compared to the control 270 group. 271
Antioxidant enzyme activity in the selected tissues, i.e. the liver, muscle and kidney in 272 response to inflammation processes induced by LPS and melatonin, was found to be highly 273 tissue-specific (Table 2 ). In the liver, LPS treatment increased SOD, GR and GPx, while it 274 diminished the CAT concentration. Melatonin treatment reversed the effects of LPS on SOD, 275 D r a f t CAT and GR activity, and further increased GPx activity. In the kidney, LPS administration 276 augmented SOD and GR, while it decreased CAT and GPx activity. Melatonin reversed the 277 effects of LPS in kidney. In the muscle, LPS injection elevated CAT, GR and GPx activity, 278 and did not influence the SOD concentration. Melatonin administration further increased GPx, 279 augmented SOD and did not change CAT and GR.In the present study, we observed 280 correlative dependences between the analyzed oxidative stress data and the activity of 281 antioxidant enzymes upon LPS and melatonin treatment. After LPS, the following 282 interdependences were observed: in the liver, a significant relationship between the SOD and 283 MDA (r=0.97, p=0.020), conjugated dienes and TAC (r=0.89, p=0.001), and OMP AD and 284 TAC (r=0.89, p=0.002) was found; in the muscle, interrelations were observed between the 285 OMP AD and CAT (r=0.98, p=0.000), TAC and GPx (r=0.88, p=0.003), and MDA and GR 286 
